A phase 1/2 dose‐finding, safety, and activity study of cabazitaxel in pediatric patients with refractory solid tumors including tumors of the central nervous system

Pediatric Blood &Cancer, EarlyView.


from Cancer via ola Kala on Inoreader https://ift.tt/2Ggg6Pc
via IFTTT